OAM
PRCT icon

Ostrum Asset Management’s Procept Biorobotics PRCT Stock Holding History

Ostrum Asset Management’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-510
Closed -$29.7K – 620
2025
Q1 		$29.7K Buy
+510
New +$34.8K ﹤0.01% 635

Other funds holding PRCT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Ostrum Asset Management's PRCT Position: Q2 2025 in Review

Ostrum Asset Management sold out of Procept Biorobotics (PRCT) in Q2 2025, closing a stake of 510 shares — an estimated $29.7K sold.

Ostrum Asset Management first reported a position in PRCT in Q1 2025 and held it in 1 quarter. The position peaked at $29.7K in Q1 2025. 271 funds tracked by Wall St. Rank hold PRCT as of Q2 2025.

  • Ostrum Asset Management reported no remaining Procept Biorobotics position as of Q2 2025 after selling out during the quarter.
  • Ostrum Asset Management sold 510 Procept Biorobotics shares in Q2 2025, an estimated $29.7K.
  • Ostrum Asset Management first reported a position in Procept Biorobotics in Q1 2025 and held it in 1 quarter.
  • Ostrum Asset Management's Procept Biorobotics position peaked at $29.7K in Q1 2025.
  • 271 funds tracked by Wall St. Rank held Procept Biorobotics as of Q2 2025.

Based on Ostrum Asset Management's 13F filing for Q2 2025, filed 13 Aug 2025.